Thromb Haemost 1997; 78(02): 934-938
DOI: 10.1055/s-0038-1657655
Rapid Communication
Schattauer GmbH Stuttgart

Perturbation of Platelet Adhesion to Endothelial Cells by Plasminogen Activation In Vitro

Hsiun-ing Chen
1   The Department of Physiology, National Cheng-Kung University, Tainan, Taiwan, ROC
,
Yueh-I Wu
1   The Department of Physiology, National Cheng-Kung University, Tainan, Taiwan, ROC
,
Yu-Lun Hsieh
1   The Department of Physiology, National Cheng-Kung University, Tainan, Taiwan, ROC
,
Guey-Yueh Shi
2   The Department of Biochemistry, National Cheng-Kung University, Tainan, Taiwan, ROC
,
Meei-Jyh Jiang
3   The Department of Anatomy, National Cheng-Kung University, Tainan, Taiwan, ROC
,
Wen-Chang Chang
4   The Department of Pharmacology, National Cheng-Kung University, Tainan, Taiwan, ROC
,
Woei-Jer Chuang
2   The Department of Biochemistry, National Cheng-Kung University, Tainan, Taiwan, ROC
,
Wai-Ming Kan
4   The Department of Pharmacology, National Cheng-Kung University, Tainan, Taiwan, ROC
,
Ming-Jer Tang
1   The Department of Physiology, National Cheng-Kung University, Tainan, Taiwan, ROC
,
Chauying J Jen
1   The Department of Physiology, National Cheng-Kung University, Tainan, Taiwan, ROC
› Author Affiliations
Further Information

Publication History

Received 07 1997

Accepted after revision 17 March 1997

Publication Date:
12 July 2018 (online)

Summary

To investigate whether the endothelium-platelet interactions may be altered by plasminogen activation, cultured human umbilical vein endothelial cells (ECs) were treated with tissue-type plasminogen activator (t-PA) in the presence of plasminogen, and platelet adhesion to ECs was subsequently measured by using a tapered flow chamber. Our results demonstrated that platelets adhered more readily to t-PA treated EC monolayer than to the control monolayer at all shear stress levels tested. This phenomenon was treatment time-dependent and dose-dependent, and it could be blocked by adding plasmin inhibitors, such as e-amino caproic acid and aprotinin. Adherent platelets on t-PA treated EC monolayer underwent more severe shape change than those on the control monolayer. While the extracellular matrix directly treated with t-PA attracted less platelets than the control matrix did, platelet adhesion to the matrix that was produced by t-PA-treated ECs was unaltered. These data suggest that t-PA treatment on ECs compromised antiplatelet-adhesion capability on their apical surface without altering the reactivity of their extracellular matrix towards platelets.

 
  • References

  • 1 Loscalzo J, Schafer AI. Anticoagulants, antiplatelet agents, and fibrinolysis. In: Vascular Medicine, a textbook for vascular biology and disease. Loscalzo J, Creager MA, Dzau VJ. (eds) Little, Brown Co; Boston: 1992. pp 659-682
  • 2 Kerins DM, Roy L, FitzGerald GA, Fitzgerald DJ. Platelet and vascular function during coronary thrombolysis with tissue-type plasminogen activator. Circulation 1989; 80: 1718-1723
  • 3 Ohlstein EH, Storer B, Fujita T, Shebuski RJ. Tissue-type plasminogen activator and streptopkinase induce platelet hyperaggregability in the rabbit. Thromb Res 1987; 46: 575-585
  • 4 Rudd MA, George D, Amarante P, Vaughan DE, Loscalzo J. Temporal effects of thrombolytic agents on platelet function in vivo and their modulation by prostaglandins. Circ Res 1990; 67: 1175-1181
  • 5 Jen CJ, Dong H-P, Chen H-i, Wing L-Y, Tang M-J, Chang W-C, Lin M-T, Shi G-Y. Platelet adhesion following the administration of tissue-type plasminogen activator and its reversal by vitamin E in rats. Thromb Haemost 1996; 75: 101-106
  • 6 Shi GY, Hau JS, Wang SJ, Wu IS, Chang BI, Lin MT, Chow YH, Chang WC, Wing LYC, Jen CJ, Wu HL. Plasmin and the regulation of tissue-type plasminogen activator biosynthesis in human endothelial cells. J Biol Chem 1992; 267: 19363-19368
  • 7 Shi GY, Wang SJ, Chang BI, Tsai CF, Lin MT, Chang WC, Wing LYC, Jen CJ, Wu HL. Regulation of plasminogen activator inhibitor activity by plasmin in endothelial cells. Thromb Res 1996; 81: 75-84
  • 8 Okajima K, Abe H, Binder BR. Endothelial cell injury induced by plasmin in vitro. J Lab Clin Med 1995; 126: 377-384
  • 9 Conforti G, Dominguez-Jimenez C, Ronne E, Hoyer-Hansen G, Dejana E. Cell-surface plasminogen activation causes a retraction of in vitro cultured human umbilical vein endothelial cell monolayer. Blood 1994; 83: 994-1005
  • 10 De GrootPG, Reinders JH, Sixma JJ. Perturbation of human endothelial cells by thrombin or PMA changes the reactivity of their extracellular matrix towards platelets. J Cell Biol 1987; 104: 697-704
  • 11 Zwaginga JJ, Sixma JJ, de GrootPG. Activation of endothelial cells induces platelet thrombus formation on their matrix. Arteriosclerosis 1990; 10: 49-61
  • 12 Usami S, Chen HH, Zhao Y, Chien S, Skalak R. Design and construction of a linear shear stress flow chamber. Ann Biomed Eng 1993; 21: 77-83
  • 13 Jen CJ, Li HM, Wang JS, Chen HI, Usami S. Flow-induced detachment of adherent platelets from fibrinogen-coated surface. Am J Physiol 1996; 270: HI60-HI66
  • 14 Chang WC, Shi GY, Chow YH, Chang LC, Hau JS, Lin MT, Jen CJ, Wing LYC, Wu HL. Human plasmin induces a receptor-mediated arachidonate release coupled with G proteins in endothelial cells. Am J Physiol 1993; 264: C271-C281
  • 15 Schroeter D, Spiess E, Paweletz N, Benke R. A procedure for rupture-free preparation of confluently grown monolayer cells for scanning electron microscopy. J Elec Micro Tech 1984; 01: 219-225
  • 16 Schafer AI, Rodriguez R, Loscalzo J, Gimbrone MA. Inhibition of vascular endothelial cell prostacyclin synthesis by plasmin. Blood 1989; 74: 1015-1020
  • 17 Kaji T, Hiraga S, Fuji N, Yamamoto C, Sakamoto M, Kozuka H, Koizumi F. Plasmin-induced reduction of heparan sulfate in cultured vascular endothelial cell layer. Thromb Res 1994; 74: 85-93
  • 18 Montrucchio G, Bergerone S, Bussolino F, Alloatti G, Silvestro L, Lupia E, Cravetto A, De LeoM, Emanuelli G, Camussi G. Streptokinase induces intravascular release of platelet-activating factor in patients with myocardial infarction and stimulates its synthesis by cultured human endothelial cells. Circulation 1993; 88: 1476-1483
  • 19 Reininger AJ, Reininger CB, Wurzinger LJ. The influence of fluid dynamics upon adhesion of ADP-stimulated human platelets to endothelial cells. Thromb Res 1993; 71: 245-249
  • 20 Van IjzendoomSCD, Heemskerk JWM, Reutelingsperger CPM. Interactions between endothelial cells and blood platelets. Endothelium 1995; 03: 81-98
  • 21 Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 02: 1057-1058
  • 22 Jen CJ, Chen CT, Chen HI. Endogenous endothelium-derived relaxing factor inhibits platelet adhesion under whole blood flow conditions ex vivo. Chin J Physiol 1995; 38: 147-151
  • 23 Johnson CM, Helgeson SC. Platelet adherence to cardiac and noncardiac endothelial cells in culture: lack of a prostacyclin effect. J Lab Clin Med 1988; 112: 372-379
  • 24 Radomski MW, Vallance P, Whitley G, Foxwell N, Moncada S. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine-induced nitric oxide. Cardiovas Res 1993; 27: 1380-1382
  • 25 Furie B, Furie BC. The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes. Thromb Haemost 1995; 74: 224-227
  • 26 Montrucchio G, Lupia E, De MartinoA, Silvestro L, Rizea SavuS, Cacace G, De FilippiPG, Emanuelli G, Camussi G. Plasmin promotes an endothelium-dependent adhesion of neutrophils: involvement of platelet activating factor and P-selectin. Circulation 1996; 93: 2152-2160
  • 27 Booth F, Allington MJ, Cederholm-Williams SA. An in vitro model for study of acute release of von Willebrand factor from human endothelial cells. Br J Haemat 1987; 67: 71-78
  • 28 Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 288-297